THE PROLIFERATIVE-DIFFERENTIAL PROCESSES IN BONE MARROW UNDER CHEMOTHERAPY DELIVERY DEPENDING ON THE IRON METABOLISM

D A Bazyka1, V A Zhovnir1, K M Bruslova1

  • 1State Institution «National Research Center for Radiation Medicine, Hematology and Oncology of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka Str., Kyiv, 04050, Ukraine.

Insights

Iron metabolism significantly influences hematopoietic recovery in children with acute lymphoid leukemia (ALL) undergoing chemotherapy. Excess iron negatively impacts prognosis, highlighting its critical role in treatment outcomes.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Iron Metabolism

Background:

  • Acute lymphoid leukemia (ALL) is a significant pediatric cancer.
  • Chemotherapy (CT) is a primary treatment for ALL.
  • Understanding factors influencing treatment response is crucial.

Purpose of the Study:

  • To assess the role of iron metabolism in hematopoietic recovery during CT for pediatric ALL.
  • To evaluate the impact of iron levels on treatment outcomes in ALL patients from radiologically contaminated territories (RCT).

Main Methods:

  • Studied 61 children (3-15 years) with ALL receiving CT.
  • Monitored hemogram, myelogram, serum iron, ferritin, and transferrin levels throughout treatment.
  • Assessed bone marrow (BM) cellularity and recovery types (granulocytic, erythroid, monocytic).

Main Results:

  • BM cellularity decreased during induction therapy and increased during consolidation.
  • Granulocytic recovery was most common; erythroid and monocytic types were less frequent.
  • Elevated serum iron and ferritin levels were observed in 37.7% and 24.6% of patients, respectively, post-CT.
  • Higher iron levels correlated with poorer prognosis and were more pronounced in proB ALL.
  • Radiation dose to BM did not affect recovery type or iron metabolism.

Conclusions:

  • Hematopoietic recovery in ALL patients under CT is dependent on iron metabolism.
  • Excess iron in the body is associated with a negative prognosis in pediatric ALL.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
809
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.1K